Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating a topical thermoresponsive hydrogel containing dexamethasone sodium phosphate and diclofenac sodium to study its effects on postoperative pain and facial swelling in patients undergoing extraoral maxillofacial surgical procedures or primary closure of clean facial soft tissue wounds. This randomized, controlled trial divides participants based on fracture status and assigns them randomly to receive either the active hydrogel or a placebo. The study aims to assess pain levels, swelling, wound healing, adverse events, patient satisfaction, and the use of additional pain medications during the postoperative period. Participants will be treated with either the active hydrogel formulation containing dexamethasone and diclofenac or a placebo hydrogel without active ingredients. The treatment will be applied topically on facial soft tissue wounds following surgery or injury. Participants are grouped into a Pluronic Hydrogel Group receiving the active drug or a Placebo Control Group receiving the hydrogel base only. During the study, participants will be evaluated for postoperative pain severity and facial swelling at baseline, 8 hours, 3 days, and 7 days after treatment. Wound healing progress, any adverse effects, patient satisfaction, and the use of rescue analgesics will also be monitored throughout the recovery period. The trial will continue until the study completion date, with all assessments focused on postoperative outcomes.